Compugen CGEN
NASDAQ CGEN
$2.59 +0.03 (+1.37%)
At close: Sep 4, 2026 · 4:00 PM EDT

Compugen (CGEN) Current Deferred Tax Assets (2019 - 2026)

Compugen (CGEN) posted quarterly Current Deferred Tax Assets of $2.5 million for Q1 2026, down 9.89% year-over-year from $2.8 million in Q1 2025, and down 1.39% on a QoQ basis from $2.5 million in Q4 2025.

Analysis

Compugen (CGEN) Current Deferred Tax Assets (2019 - 2026) Analysis & Trends

Compugen has reported Current Deferred Tax Assets for 8 years, with the latest figure at $2.5 million in Q1 2026.

  • Current Deferred Tax Assets for Q1 2026 came in at $2.5 million, down 9.89% year-over-year; the trailing twelve-month figure through Mar 2026 was $2.5 million (down 9.89% YoY), and the FY2025 annual result was $2.5 million, down 11.33% from the prior year.
  • Current Deferred Tax Assets fell to $2.5 million in Q1 2026, from $2.5 million in the prior quarter.
  • Over five years, Current Deferred Tax Assets peaked at $3.1 million in Q1 2024 and troughed at $1.3 million in Q4 2023.
  • A 5-year average of $2.3 million and a median of $2.5 million in 2026 frame the typical range for Current Deferred Tax Assets.
  • The widest annual swing landed in 2023, when Current Deferred Tax Assets declined 27.22%; it then soared 113.92% in 2024.
  • A 5-year view of Current Deferred Tax Assets shows it stood at $1.8 million in 2022, then declined by 27.22% to $1.3 million in 2023, then soared by 113.92% to $2.8 million in 2024, then fell by 11.33% to $2.5 million in 2025, then declined by 1.39% to $2.5 million in 2026.
  • Per Business Quant data, the three most recent Current Deferred Tax Assets figures were $2.5 million in Q1 2026, $2.5 million in Q4 2025, and $2.6 million in Q3 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn
10 Compugen 242.44 Mn 156.82 Mn -92,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 2.42 Mn
Mar 31, 2026 2.49 Mn
Dec 31, 2025 2.52 Mn
Sep 30, 2025 2.60 Mn
Jun 30, 2025 2.68 Mn
Mar 31, 2025 2.76 Mn
Dec 31, 2024 2.84 Mn
Sep 30, 2024 2.95 Mn
Jun 30, 2024 3.06 Mn
Mar 31, 2024 3.08 Mn
Dec 31, 2023 1.33 Mn
Sep 30, 2023 1.43 Mn
Jun 30, 2023 1.61 Mn
Mar 31, 2023 1.75 Mn
Dec 31, 2022 1.83 Mn
Sep 30, 2022 1.86 Mn
Jun 30, 2022 1.95 Mn
Mar 31, 2022 2.12 Mn
Dec 31, 2021 2.25 Mn
Sep 30, 2021 2.35 Mn